Collaborate2Cure: Innovations in Treatment, Therapy, and Care in Rare Disease

Lunch will be provided for in person attendees.

Agenda
11:30 – 11:45 AM | Check in and Networking (in-person attendees only)

11:45 AM | Program

• • Welcome: Thomas Spencer, PhD, Curators Distinguished Professor & Vice Chancellor for Research and Economic Development, University of Missouri
  • Moderator: David Arnold, MD, Executive Director of the NextGen Precision Health Initiative,University of Missouri
  • Speakers:
    • Claire Elson, PharmD, BCPPS, Clinical Pharmacy Specialist – Cystic Fibrosis/Pulmonology, Children’s Mercy and Chair, Rare Disease Advisory Council (RDAC) for Missouri
    • Chris Lorson, PhD, Curators’ Distinguished Professor and Associate Vice Chancellor for Research, University of Missouri and Chief Scientific Officer of Shift Pharmaceuticals
    • Dongsheng Duan, PhD, Curators’ Distinguished Professor and Margaret Proctor Mulligan Professor in Medical Research Professor, University of Missouri
    • Scott McGoohan, JD, Executive Director, Policy & Alliance Development, US Public Affairs, Vertex Pharmaceuticals

Registration is free, but required.